Dementia U-Care: Comprehensive Cognitive Screening Application for Seniors
Article Sidebar
Main Article Content
Abstract
The prevalence of cognitive impairment increases with age, particularly impacting seniors as it advances to severe dementia. These conditions pose significant challenges for afflicted individuals and their caregivers, manifesting as profound impacts on daily life and imposing considerable emotional and financial burdens on families. Mild cognitive impairment (MCI) denotes an intermediate stage between normal cognitive function and dementia, signifying a decline in cognitive abilities while maintaining normal daily life activities. Identifying MCI early in seniors within the community is pivotal to preventing further cognitive decline.
In response to the challenge of traditional cognitive function assessments, which require trained healthcare professionals and take 20-30 minutes per case, we introduce "Dementia U-Care," an innovative app designed to assist community health workers in screening, monitoring, and collecting cognitive data. Accessible on mobile devices, it allows seniors to respond through drawing and writing, simplifying data collection compared to paper forms. Dementia U-Care streamlines preliminary assessments, empowering professionals and reducing fatigue and errors. This tool enables prompt screening, minimizing test-related stress, with an average testing time of 13.06 minutes, ranging from 9 to 20 minutes. The evaluation indicates high satisfaction with Dementia U-Care, with a mean score of 9.37±1.12. Users are generally pleased with its quality and user experience, demonstrating its effectiveness in meeting their needs and providing a positive experience.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
R.S. Wilson, T. Wang, L. Yu, D.A. Bennett and P.A. Boyle, “Normative cognitive decline in old age,” Annals of neurology, Vol. 87, No. 6, pp. 816-829, 2020.
L. Neubert, H.H. König, M.Löbner, M.Luppa, M.Pentzek, A. Fuchs, and C. Brettschneider, “Excess costs of dementia in old age (85+) in Germany: results from the AgeCoDe-AgeQualiDe study,”The Journal of the Economics of Ageing, Vol. 20, No. 1, pp 100346, 2021.
R. Wittenberg, M. Knapp, B. Hu, A. Comas‐Herrera, D. King, A.Rehill andA. Kingston, “The costs of dementia in England,” International journal of geriatric psychiatry, Vol. 34, No. 7, pp. 1095-1103, 2019.
A. Wimo, K.Seeher, R.Cataldi, E.Cyhlarova, J.L.Dielemann, O.Frisell, O and T.Dua, “The worldwide costs of dementia in 2019,” Alzheimer's & Dementia, Vol. 19 No. 7, pp. 2865-2873, 2023.
Q. Cao, C. Tan, W. Xu, H. Hu, X.P. Cao, Q. Dong, Q and J.T. Yu, “The prevalence of dementia: a systematic review and meta-analysis,” Journal of Alzheimer's Disease, Vol. 73, No. 3, pp. 1157-1166, 2020.
A. Christogianni and S.H. Suroya, Multimorbidity Case Studies in Dementia Patients, IGI Global, Hershey, 2023. ch. 006.
L. Bidzan,“Cardiovascular factors in dementia,” PsychiatriaPolska, Vol. 56, No. 5,pp. 991–1001,2022.
A.D. Kurnia, A.Krisnanda, N.L. Masruroh and N.Melizza, “Factors Related to the Quality of Life among Elderly with Dementia: A Scoping Review,” Jurnal Aisyah: Jurnal Ilmu Kesehatan, Vol. 8, No. 2, pp. 963-970, 2023.
M.J. Andersson and J. Stone, “Best Medicine for Dementia: The Life-Long Defense of the Brain,” Journal of Alzheimer's Disease, Vol. 94, No. 1, pp. 1-16, 2023.
S.F. MHI, O.A. Ibrahim, Y. Wang and M. Vassilaki, Prediction of Incident Dementia Using Patient Temporal Health Status, Studies in health technology and informatics, pp. 757-761, 2022.
E.B. Larson, “Prospects for delaying the rising tide of worldwide, late-life dementias,” International Psychogeriatrics, Vol. 22, No. 8, pp. 1196-1202, 2010.
T.C. Pinto, L. Machado, T.M. Bulgacov, A.L. Rodrigues-Júnior, M.L. Costa, R.C. Ximenes and E.B. Sougey, “Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer’s Disease (AD) in the elderly?,” International psychogeriatrics, Vol. 31, No. 4, pp. 491-504, 2019.
G.S. Siqueira, P.D.M. Hagemann, D.D.S. Coelho, F.H.D. Santos and P.H. Bertolucci, “Can MoCA and MMSE be interchangeable cognitive screening tools? A systematic review,” The Gerontologist, Vol. 59, No. 6, pp. e743-e763, 2019.
M. Shetty, M. Bhat and M. Devadiga, “Detection of Alzheimer's Disease Using Machine Learning,”IEEEInternational Conference on Artificial Intelligence and Data Engineering (AIDE), pp. 117-120, 2022.
M. Bahaj, and N. Gherabi, “Comparative Study of Dimensionality Reduction Techniques and Machine Learning
Algorithms for Alzheimer's Disease Classification and Prediction,” IEEE 3rd International Conference on Electronics, Control, Optimization and Computer Science (ICECOCS), pp. 1-6, 2022.
S. Zgonec, “Mobile Apps Supporting People with Dementia and Their Carers: Literature Review and Research Agenda,” IFAC-Papers OnLine, Vol. 54, No. 13, pp. 663-668, 2021.
C. Yamagata, J.F. Coppola, M. Kowtko, S. Joyce, “Mobile App Development and Usability Research to Help Dementia and Alzheimer Patients,” IEEE Long Island Systems, Applications and Technology Conference (LISAT), pp. 1-6, 2021.
M. Do, B.K.H. Bui, N.K.N.K. Pham, P.Anglewicz, L. Nguyen, T. Nguyen and M.Landingham, “Validation of MoCA test in Vietnamese language for cognitive impairment screening,”Journal of Global Health Neurology and Psychiatry, e2022008, pp. 1-17, 2022.
G. Ramirez-Garcia, V. Galvez, R. Diaz, A. Campos-Romo and J. Fernandez-Ruiz, “Montreal Cognitive Assessment (MoCA) performance in Huntington’s disease patients correlates with cortical and caudate atrophy,” PeerJ, 10, e12917.
P. Kantithammakorn, P. Punyabukkana, P.N. Pratanwanich, S. Hemrungrojn, C. Chunharas and D. Wanvarie, “Using automatic speech recognition to assess Thai speech language fluency in the Montreal cognitive assessment (MoCA),” Sensors, Vol. 22, No. 4, pp. 1583, 2022.
M. Bucholc, C. James, A.A. Khleifat, A. Badhwar, N. Clarke, A. Dehsarvi and J.M. Ranson, “Artificial intelligence for dementia research methods optimization,” Alzheimer's & Dementia, 2023.
F. Thabtah, D. Peebles, J. Retzler and C. Hathurusingha, “A review of dementia screening tools based on Mobile application,” Health and Technology, Vol. 10, No. 5, pp. 1011-1022, 2020.
E.S. Mendis, L.W. Kasthuriarachchi, H.P.K.L. Samarasinha, S. Kasthuriarachchi and S. Rajapaksa, “Mobile Application for Mental Health Using Machine Learning,” IEEE 4th International Conference on Advancements in Computing (ICAC), pp. 387-392, 2022.
S. Hemrungrojn, S. Tangwongchai, T. Charoenboon, M. Panasawat, T. Supasitthumrong, P. Chaipresertsud and M. Maes, “Use of the Montreal Cognitive Assessment Thai version to discriminate amnestic mild cognitive impairment from Alzheimer’s disease and healthy controls: machine learning results,” Dementia and Geriatric Cognitive Disorders, Vol. 50, No. 2, pp. 183-194, 2021.
R. Jewprasertpan, “The Effects of Cognitive Stimulation Program in Elderly People with Mild Cognitive Impairment,” Buddhachinaraj Medical Journal, Vol. 37, No.2, pp. 217-225, 2020.
R. Sangna, K. Pinyopornpanish, W. Jiraporncharoen, and C. Angkurawaranon, “Validation of a 14-item self-reporting questionnaire for the screening of dementia in the elderly,” Journal of Mental Health of Thailand, Vol. 28, No. 3, pp. 199–210, 2021.